The firm is now focused on an organic growth strategy emphasizing brand consolidation, operational efficiency, improved distribution, and product expansion. The company’s core strategic priorities ...

The Federal Reserve’s recent moves and Bank of America’s cautious outlook for 2025 have created an interesting setup for ...

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year ...